Exculpatory language

IRB Committee Member Help: Does the process of consent, including advertisements and recruitment materials, include exculpatory language where the participant waives, or appears to waive their rights?

Belmont principle Respect for Persons
Where to start: initial application Read all advertising and recruitment materials, the description for the process of consent, and the consent documents
Where to start: continuing review application Read all advertising and recruitment materials, the description for the process of consent, and the consent documents
Required IRB determinations No informed consent, whether oral or written, may include any exculpatory language through which the subject or the representative is made to waive or appear to waive any of the subject's legal rights, or releases or appears to release the investigator, the sponsor, the institution or its agents from liability for negligence. (45 CFR §46.116; 21 CFR §50)
  “Exculpatory language” means language in the consent where the participant in research appears to waive certain legal rights, or to indemnify the researcher in the event the participant is injured. To “indemnify” means to release, or appear to release the investigator, the sponsor, the institution or its agents from liability for negligence.IRB committee members may not approve a consent process that includes exculpatory language. Federal regulations specify that “No informed consent, whether oral or written, may include any exculpatory language through which the subject or the representative is made to waive or appear to waive any of the subject's legal rights, or releases or appears to release the investigator, the sponsor, the institution or its agents from liability for negligence.” (45 CFR §46.116; 21 CFR §50)Recruitment methods, including advertisements and payment or reimbursement arrangements are part of the consent process. IRBs should evaluate the entire process and documentation of consent, from advertising and recruitment, to the documentation of consent, to insure that participants or their legally authorized representatives are not asked to waive their rights, or indemnify the sponsor.Examples of language where the participant appears to waive their rights include:
  • By agreeing to this use, you should understand that you will give up all claim to personal benefit from commercial or other use of these substances.
  • I voluntarily and freely donate any and all blood, urine, and tissue samples to the U.S. Government and hereby relinquish all right, title, and interest to said items.
  • By consent to participate in this research, I give up any property rights I may have in bodily fluids or tissue samples obtained in the course of the research.
Examples where the participant appears to indemnify the research sponsor or organization include:
  • I waive any possibility of compensation for injuries that I may receive as a result of participation in this research.
  • I agree to hold harmless the sponsor, the Department, and the investigators if I am injured by participating in the research study.
  • I acknowledge that participating in research can be risky, and that I understand that if I am injured, it is not the fault of the investigator, the organization, or the sponsor.
Examples of acceptable language
  • Tissue obtained from you in this research may be used to establish a cell line that could be patented and licensed. There are no plans to provide financial compensation to you should this occur.
  • By consenting to participate, you authorize the use of your bodily fluids and tissue samples for the research described above.
  • There are no funds set aside to provide financial compensation or absorb the costs of medical treatment if you are injured as a result of participating in this research.
  • This Department makes no commitment to provide free medical care or payment for any unfavorable outcomes resulting from participation in this research. Medical services will be offered at the usual charge.
Accreditation Element Element II.3.C.1. The IRB or EC has and follows written policies and procedures to review proposed participant recruitment methods, advertising materials, and payment arrangements and determines whether such arrangements are fair, accurate, and appropriate.
Regulations 45 CFR §46.116; 21 CFR §50;
Guidance FDA Information Sheets: Frequently Asked Questions: Informed Consent
OHRP Guidebook Chapter 3: Basic IRB Review, Consent
eZ publish™ copyright © 1999-2012 eZ systems as